Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability

Cytokine. 2020 Jan:125:154798. doi: 10.1016/j.cyto.2019.154798. Epub 2019 Aug 17.

Abstract

Background: IL-36 family, a recently reported member of the IL-1 cytokine family, plays an essential role in nonspecific innate immune response to infection. This study aims at investigating the expression of IL-36 family members (α, β, and γ) in normal and inflammatory sinus mucosa of patients with chronic rhinosinusitis (CRS), their effects on chemokine secretion and on the barrier function of epithelial and endothelial cells, and the effect of Toll-like receptors on the expression of IL-36 in epithelial cells.

Material and methods: The expression of IL-36 family in normal and inflammatory sinus mucosa, the production of chemokines or the expression levels of IL-36 family in epithelial cells treated with IL-36 family members or stimulated with TLR3, TLR4, TLR5, or TLR7/8 agonists were measured with real time PCR, ELISA, immunohistochemistry, or Western blot. The epithelial and endothelial permeability, and transendothelial leukocyte migration were investigated using cultured epithelial and endothelial cells.

Results: IL-36α, IL-36β, and IL-36γ were localized in epithelial cells of sinonasal mucosa. Their levels increased in inflammatory mucosa of CRS patients and are up-regulated by TLR3, TLR4, or TLR5 agonists. IL-36α, or IL-36γ induced CXCL1, CXCL2, and CXCL3 production. Epithelial and endothelial permeability, transendothelial leukocyte migration were increased in cells treated with IL-36α, IL-36β, or IL-36γ.

Conclusions: These results suggest that IL-36α, IL-36β, and IL-36γ localized in superficial epithelium may act as a responder to microbial and nonmicrobial elements through TLR and subsequently produce CXC chemokines, playing an interplay between innate and adaptive immune response.

Keywords: Chemokines; Epithelial permeability; IL-36α; IL-36β; IL-36γ; TLR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cell Movement / drug effects
  • Chemokines / metabolism*
  • Chronic Disease
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / physiology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Epithelial Cells / physiology
  • Flagellin / pharmacology
  • Humans
  • Immunohistochemistry
  • Inflammation / genetics
  • Inflammation / metabolism
  • Interleukin-1 / genetics
  • Interleukin-1 / metabolism*
  • Interleukin-1 / pharmacology*
  • Leukocytes / drug effects
  • Leukocytes / metabolism
  • Lipopolysaccharides / pharmacology
  • Middle Aged
  • Nasal Mucosa / metabolism
  • Permeability
  • Real-Time Polymerase Chain Reaction
  • Sinusitis / genetics
  • Sinusitis / metabolism*
  • Toll-Like Receptor 3 / agonists
  • Toll-Like Receptor 3 / metabolism
  • Toll-Like Receptor 4 / agonists
  • Toll-Like Receptor 4 / metabolism
  • Toll-Like Receptor 5 / agonists
  • Toll-Like Receptor 5 / metabolism
  • Toll-Like Receptor 7 / agonists
  • Toll-Like Receptor 7 / metabolism
  • Toll-Like Receptor 8 / agonists
  • Toll-Like Receptor 8 / metabolism
  • Toll-Like Receptors / agonists*
  • Toll-Like Receptors / metabolism

Substances

  • Chemokines
  • IL36G protein, human
  • Interleukin-1
  • Lipopolysaccharides
  • TLR3 protein, human
  • TLR4 protein, human
  • TLR5 protein, human
  • TLR7 protein, human
  • TLR8 protein, human
  • Toll-Like Receptor 3
  • Toll-Like Receptor 4
  • Toll-Like Receptor 5
  • Toll-Like Receptor 7
  • Toll-Like Receptor 8
  • Toll-Like Receptors
  • interleukin 36, human
  • Flagellin